S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
OTCMKTS:ICOTF

iCo Therapeutics (ICOTF) Stock Price, News & Analysis

→ With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (From DTI) (Ad)
Free ICOTF Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.37
▼
$0.39
50-Day Range
$0.30
▼
$0.42
52-Week Range
$0.80
▼
$1.82
Volume
29,150 shs
Average Volume
4,760 shs
Market Capitalization
$3.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ICOTF stock logo

About iCo Therapeutics Stock (OTCMKTS:ICOTF)

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.

ICOTF Stock News Headlines

May 10, 2023 | wsj.com
ICO Group Ltd.
February 25, 2023 | marketwatch.com
Antisense & RNAi Therapeutics Market 2023 Estimated to Perceive Exponential Growth till 2028
April 19, 2024 | Paradigm Press (Ad)
Biden replacement revealed?
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
February 19, 2023 | finance.yahoo.com
Women's health therapeutics market size to increase by USD 30.35 billion: North America to account for 37% of market growth - Technavio
February 19, 2023 | seekingalpha.com
Jasper Therapeutics releases promising early-stage data on sickle cell disease treatment
October 10, 2022 | usnews.com
Consumers to Ditch Cafes for Coffee at Home Amid Rising Prices, Says ICO
August 16, 2022 | investing.com
Satellos Bioscience Inc (MSCL)
June 1, 2022 | seekingalpha.com
Satellos Bioscience GAAP EPS of -C$0.06
April 19, 2024 | Paradigm Press (Ad)
Biden replacement revealed?
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
December 16, 2021 | finance.yahoo.com
Satellos Bioscience Inc. Announces Scientific Research Agreement with Université de Sherbrooke to Study Rare Muscular Dystrophies
December 15, 2021 | finance.yahoo.com
Satellos Bioscience to Webcast Live at Life Sciences Investor Forum December 16th
December 9, 2021 | finance.yahoo.com
ICOTF: Targeting Stem Cells for Muscular Dystrophy Treatment
December 6, 2021 | finance.yahoo.com
Satellos Bioscience Announces New Board Appointments
December 2, 2021 | investing.com
iCo Therapeutics Inc (MSCL)
November 29, 2021 | finance.yahoo.com
Satellos Bioscience Reports Third Quarter 2021 Financial Results and Operational Highlights
October 27, 2021 | finance.yahoo.com
Satellos Bioscience Inc. Retains BND Projects Inc. for Strategic Investor Relations Services
August 5, 2021 | finance.yahoo.com
iCo Therapeutics Inc. Announces Shareholder Approval of Business Combination with Satellos Bioscience Inc.
See More Headlines
Receive ICOTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ICOTF
CUSIP
N/A
CIK
N/A
Web
www.icotherapeutics.com
Phone
(905) 336-6128
Fax
604-602-9699
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,110,000.00
Net Margins
N/A
Pretax Margin
-4,148.78%
Return on Equity
N/A
Return on Assets
-288.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.72
Quick Ratio
0.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-5.57

Miscellaneous

Outstanding Shares
9,054,000
Free Float
N/A
Market Cap
$3.53 million
Optionable
Not Optionable
Beta
2.03
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Frank Gleeson
    President & Chief Executive Officer
  • Warren Whitehead
    Chief Financial Officer
  • Michael Rudnicki
    Chief Scientific Officer
  • J. Robert Hall
    Vice President-Finance & Administration

Key Competitors

View All Competitors

This page (OTCMKTS:ICOTF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Options trading has suddenly become more reliable.
Eagle Publishing
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends